Proxima Fusion
Germany
- Munich, Bavaria
- 31/05/2023
- Pre-Seed
- $7,479,000
Designing optimised stellarator fusion reactors - the most promising and robust concept for a fusion power plant.
- Industry Electric Power Generation
- Website https://www.proximafusion.com/
- LinkedIn https://www.linkedin.com/company/proximafusion/
Related People
Francesco SciortinoCo Founder
Germany -
Munich, Bavaria
I am a co-founder and CEO of Proxima Fusion, a fusion energy startup based in Munich, spun out of the Max Planck Institute for Plasma Physics. At Proxima, we are working towards fusion power plants based on quasi-isodynamic stellarators. We see Wendelstein 7-X (W7-X), the most advanced stellarator in the world, as showing the clearest and most robust path to fusion energy. I believe that Europe has tremendous advantages when it comes to stellarator R&D, and that successful innovation requires not only creativity but also courage to break with the status quo.
I completed my PhD in plasma physics and fusion energy at MIT in 2021. My PhD research focused on the Alcator C-Mod and DIII-D tokamaks in the USA, particularly on the application of reduced models, optimization and Bayesian inference for fusion. After my PhD, I joined the Max-Planck-Institut für Plasmaphysik in Germany, working on divertor spectroscopy and numerical optimization on the ASDEX-Upgrade tokamak and the W7-X stellarator. During this time, I was one of the European Scientific Coordinators for experimental research on negative triangularity tokamak scenarios.
I previously worked on research projects at the MAGPIE Z-pinch facility at Imperial College London (UK), at the TCV tokamak at EPFL (Switzerland), at the Magnetic Reconnection Experiment at the Princeton Plasma Physics Laboratory (USA), and at the APEX-D facility at the MPI-IPP (Germany).
Leona Health | $14,000,000 | (Dec 18, 2025)
Limenet | $8,217,860 | (Dec 18, 2025)
Codoxo | $35,000,000 | (Dec 18, 2025)
Drive Health | $15,000,000 | (Dec 18, 2025)
DataLane | $22,500,000 | (Dec 18, 2025)
Addition Therapeutics | $100,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)
Scylos | $3,000,000 | (Dec 18, 2025)
Last Energy | $100,000,000 | (Dec 18, 2025)
Navier AI | $6,500,000 | (Dec 17, 2025)
Verisoul | $8,800,000 | (Dec 17, 2025)
Aeovian Pharmaceuticals | $55,000,000 | (Dec 17, 2025)